A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy.

Hiroaki Sato Tomokazu SazukaAyumi FujimotoSakurako KagitaniTakayuki AraiYusuke GotoYusuke ImamuraShinichi SakamotoJun-Ichiro IkedaTomohiko Ichikawa

Published in: IJU case reports (2023)

Deferred cytoreductive nephrectomy following a lenvatinib plus pembrolizumab combination is a useful therapeutic strategy for achieving complete remission of metastatic renal cell carcinomas.

Keyphrases

metastatic renal cell carcinoma
combination therapy
robot assisted
advanced non small cell lung cancer
editorial comment
small cell lung cancer
squamous cell carcinoma
single cell
cell therapy
high grade
minimally invasive
disease activity
rheumatoid arthritis
epidermal growth factor receptor